Effect of Dexamethasone on Nocturnal Oxygenation in Lowlanders With Chronic Obstructive Pulmonary Disease Traveling to 3100 Meters: A Randomized Clinical Trial

JAMA Network Open
Michael FurianKonrad Ernst Bloch

Abstract

During mountain travel, patients with chronic obstructive pulmonary disease (COPD) are at risk of experiencing severe hypoxemia, in particular, during sleep. To evaluate whether preventive dexamethasone treatment improves nocturnal oxygenation in lowlanders with COPD at 3100 m. A randomized, placebo-controlled, double-blind, parallel trial was performed from May 1 to August 31, 2015, in 118 patients with COPD (forced expiratory volume in the first second of expiration [FEV1] >50% predicted, pulse oximetry at 760 m ≥92%) who were living at altitudes below 800 m. The study was conducted at a university hospital (760 m) and high-altitude clinic (3100 m) in Tuja-Ashu, Kyrgyz Republic. Patients underwent baseline evaluation at 760 m, were taken by bus to the clinic at 3100 m, and remained at the clinic for 2 days and nights. Participants were randomized 1:1 to receive either dexamethasone, 4 mg, orally twice daily or placebo starting 24 hours before ascent and while staying at 3100 m. Data analysis was performed from September 1, 2015, to December 31, 2016. Dexamethasone, 4 mg, orally twice daily (dexamethasone total daily dose, 8 mg) or placebo starting 24 hours before ascent and while staying at 3100 m. Difference in altitude-indu...Continue Reading

References

Feb 3, 1989·JAMA : the Journal of the American Medical Association·A B MontgomeryJ Mills
Nov 11, 1999·American Journal of Respiratory and Critical Care Medicine·R O CrapoD P Tashkin
Jul 31, 2004·The Journal of Physiology·Jerome A DempseyJames B Skatrud
May 9, 2006·Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology·Kosuke KaidaKenji Fukasawa
Oct 4, 2006·Annals of Internal Medicine·Marco MaggioriniHeimo Mairbäurl
Sep 2, 2009·The European Respiratory Journal·P W JonesN Kline Leidy
Mar 25, 2010·BMJ : British Medical Journal·Kenneth F SchulzUNKNOWN CONSORT Group
Aug 3, 2011·Thorax·Dinesh ShrikrishnaUNKNOWN Air Travel Working Party of the British Thoracic Society Standards of Care Committee
Mar 2, 2012·Sleep·Yvonne Nussbaumer-OchsnerKonrad E Bloch
Jun 30, 2012·The European Respiratory Journal·Philip H QuanjerUNKNOWN ERS Global Lung Function Initiative
Feb 11, 2014·Diabetes Research and Clinical Practice
May 3, 2014·The American Journal of Medicine·Cheng-Rong ZhengLan Huang
Jul 16, 2014·American Journal of Respiratory and Critical Care Medicine·Yuan-Ming LuoMichael Polkey
Dec 11, 2014·Sleep & Breathing = Schlaf & Atmung·Chun-Hsien TsengShi-Chuan Chang
Feb 16, 2015·The Lancet. Respiratory Medicine·R HeinzerJ Haba-Rubio
Aug 1, 2015·Journal of Applied Physiology·Konrad E BlochSilvia Ulrich
Nov 25, 2016·Respiration; International Review of Thoracic Diseases·Robert ThurnheerKonrad E Bloch
Dec 23, 2016·The European Respiratory Journal·Tsogyal D LatshangKonrad E Bloch
Mar 5, 2018·Respiration; International Review of Thoracic Diseases·Michael FurianKonrad E Bloch

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.